title: Carcinoma-in-situ of the glottic larynx: results of treatment with radiation therapy.
abstract: OBJECTIVE
  Carcinoma-in-situ (CIS) of the vocal cords frequently progresses to invasive disease if untreated. Treatment approaches include vocal cord stripping, radiation therapy (RT), and laser excision. The purpose of this analysis was to assess the efficacy and safety of a standard RT regimen in the treatment of this condition.
  
  
  METHODS
  Between January 1980 and December 1994, 67 patients (52 men, 15 women; median age, 65 years) with glottic CIS were treated with RT. The standard RT regimen was 51 Gy in 20 fractions given over 4 weeks (99% of patients). Prior to receiving RT, 21 patients (31%) had undergone 1 or 2 vocal cord stripping procedures, and 1 had been treated with laser.
  
  
  RESULTS
  With a median follow-up of 6.5 years, 1 patient developed invasive glottic cancer, giving a 5-year actuarial local control rate of 98%. This patient recurred 14 months after treatment and was salvaged with laryngectomy. He is currently free of disease 2 years after surgery. There were no serious acute or late treatment complications. Sixteen patients (24%) developed subsequent malignancies, 8 of these being in the upper aerodigestive tract, although none were in the radiation field.
  
  
  CONCLUSIONS
  Moderate-dose radiation therapy is an effective treatment for glottic CIS. It is well tolerated, produces no serious acute or long-term side effects, with an excellent cure rate.
authors: Department of Radiation Oncology, Princess Margaret Hospital/University of Toronto, Toronto, Ontario, Canada.
authors: J A
authors: JA
authors: Spayne
authors: P
authors: P
authors: Warde
authors: B
authors: B
authors: O'Sullivan
authors: D
authors: D
authors: Payne
authors: F F
authors: FF
authors: Liu
authors: J
authors: J
authors: Waldron
authors: P J
authors: PJ
authors: Gullane
authors: B J
authors: BJ
authors: Cummings
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002278:Carcinoma in Situ / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D005931:Glottis; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis; D016896:Treatment Outcome